Common IT solution for the global serialization of medicinal products
The GUS Group, a leading provider of ERP applications, and the systems integrator Arvato Systems enter into a strategic partnership and provide a common IT solution for the required EU measure to improve medication safety: Starting 2018, pharmaceutical companies are obliged to generate a unique serial number and print it on the boxes of medicinal products to ensure an end-to-end verification.
The Arvato Corporate Serialization Database (Arvato CSDB) solution developed by Arvato Systems is expanding the GUS-OS Suite for the pharmaceuticals industry and the range of products and services of the GUS Group. Peter Koop, Director of Pharmaceutical Solutions at Arvato Systems, explains: “We are delighted to now be able to offer a sustainable industry solution in Arvato CSDB with the GUS Group. Alongside the vital contribution towards combating falsified medicine, we also believe there is massive potential for serialization in supply chain optimization, which we are looking to tap with our customers and the GUS Group.”
On 21 October 2014, the two companies will present their common IT solution using live demonstrations at the GUS customer event in Berlin. The title of the event is called: “Serialization in the Pharmaceuticals Industry: Best Practices for the Future”. You can find more information on the conference, the topic, and the solutions available in this area here.
For more information about the strategic partnership of Arvato Systems and the GUS Group.